Drug GMP Report
April 2008
EC Seeks to Expand Inspections Authority for Member States
The European Commission (EC) is proposing to expand its regulations on GMP inspections by allowing member states to conduct both announced and unannounced audits of active pharmaceutical ingredient (API) production facilities.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|